These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1201397)

  • 1. Proceedings: Inhibition of 5-hydroxy-(3H)-tryptamine binding to rat blood platelets by 5-HT antagonists and uptake inhibitors.
    Drummond AH; Gordon JL
    Br J Pharmacol; 1975 Oct; 55(2):257P-258P. PubMed ID: 1201397
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cadmium treatment in vitro on the uptake and release of [3H]serotonin by human blood platelets.
    Mukhopadhyay S; Mukhopadhyay S; Addya S; Bhattacharya DK; Chatterjee GC
    Indian J Biochem Biophys; 1989 Feb; 26(1):56-60. PubMed ID: 2777314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Comparison of the effects of some anorectic drugs on platelet and brain 5-hydroxy-tryptamine (5HT) in rats.
    Roncaglioni C; Buckzo W; Samanin R; de Gaetano G; Garattini S
    Thromb Diath Haemorrh; 1975 Nov; 34(2):577. PubMed ID: 1198476
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of prodipine and budipine on 14C-5-hydroxytryptamine uptake and release by human blood platelets.
    Eltze M
    Arzneimittelforschung; 1980; 30(7):1129-34. PubMed ID: 7191294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common uptake system for serotonin and dopamine in human platelets.
    Omenn GS; Smith LT
    J Clin Invest; 1978 Aug; 62(2):235-40. PubMed ID: 670392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.
    Segonzac A; Tateishi T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):33-7. PubMed ID: 6514017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding sites for 5-hydroxytryptamine on rat blood platelets.
    Drummond AH; Gordon JL
    Biochem J; 1975 Jul; 150(1):129-32. PubMed ID: 1201004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of 5-hydroxytryptamine by blood platelets incubated in plasma from rats and humans treated with amitriptyline and imipramine.
    Tukiainen E
    Med Biol; 1981 Apr; 59(2):121-6. PubMed ID: 7311628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of anticholinergics on the uptake of serotonin by human blood platelets.
    Oxenkrug GF; Staib AH
    Acta Biol Med Ger; 1974; 33(2):253-4. PubMed ID: 4463643
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
    Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of verapamil on serotonergic mechanisms in the rat blood platelets.
    Pietraszek M; Chabielska E; Malinowska B; Buczko W
    Pol J Pharmacol Pharm; 1988; 40(1):81-6. PubMed ID: 3237561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of subsensitivity to imipramine in the system of reverse serotonin uptake by thrombocytes in patients with endogenous depression].
    Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Faktor MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(9):96-100. PubMed ID: 3232463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
    Savi P; Laplace MC; Maffrand JP; Herbert JM
    J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil inhibition of 5-hydroxytryptamine (5HT) uptake in rat platelets.
    Pietraszek MH; Buczko W
    Eur J Pharmacol; 1987 Jun; 137(2-3):273-5. PubMed ID: 3609146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of in vivo deslanoside on the uptake of serotonin into platelets.
    Helke CJ; Kellar KJ; Gillis RA
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):44-9. PubMed ID: 543748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endosulfan induced inhibition of 3H-5-hydroxytryptamine uptake in platelets.
    Anand M; Gopal K; Agrawal C; Chandra SV; Ray PK; Verma M; Shanker K
    Toxicol Lett; 1986 Sep; 32(3):203-8. PubMed ID: 3775804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.